Johnson & Johnson logo

Johnson & Johnson (JNJ) stock

JNJ · Johnson & Johnson · NYSE

Website
Market cap
$651.97B
P/E
41.2
EPS (TTM)
$6.58
Shares out
2.41B
52-week range79% up the range
$199.93$290.10

What is the latest news on JNJ stock?

JNJ rose 1.35% to $270.83 on Nov 20, 2026. No JNJ story in the last two days; the most recent is below.

PRago
Johnson & Johnson data in psoriatic arthritis (PsA) shows TREMFYA (guselkumab) is the only advanced therapy to demonstrate MRI-confirmed improvements in spinal pain and stiffness

TREMFYA showed statistically significant improvement in disease activity on the BASDAI score versus placebo, reflecting meaningful reductions in pain, stiffness, swelling and fatigue in a Phase 4 studyTREMFYA demonstrated more than 2 times greater reduction in MRI-assessed inflammation versus placebo at Week 24 in the sacroiliac joints, which connect the lower spine to the pelvis and are responsible for pain and stiffnessTREMFYA was evaluated in first-ever PsA study using objective MRI assessments to confirm and measure axial inflammation alongside patient-reported symptoms NEW BRUNSWICK, N.J., Nov. 20, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced late-breaking results f

All JNJ news
Price$270.83+3.25 (+1.21%)
2026-08-202026-11-20

When does Johnson & Johnson report earnings?

The latest Johnson & Johnson earnings release came out on Oct 13, 2026: Johnson & Johnson reports Q3 2026 results, raises 2026 guidance. Before that, Johnson & Johnson reported on Jul 22, 2026 and Apr 14, 2026. On that schedule the next report would come around mid January 2027.

JNJ earnings history

Who owns the most JNJ stock?

BlackRock, Inc. was the largest reported holder of JNJ at the end of Q2 2026, with 212,098,264 shares worth $53.9 billion. Next came Vanguard Capital Management LLC ($39.9 billion) and State Street Corp ($34.0 billion). In all, 4,673 institutions reported $457.4 billion of JNJ in their 13F filings.

All JNJ fund holders

Are insiders buying or selling JNJ?

Insiders are selling. In the last 90 days 2 insiders sold $12.9 million of JNJ in trades reported on Form 4. The latest: Elizabeth Forminard sold $3.7 million, reported on Nov 13, 2026.

JNJ insider trades

Financial highlights

Full financials
Revenue, TTM
$99.33B
Revenue growth
+7.8%
Net income, TTM
$16.09B
Net margin
16.2%
Free cash flow, TTM
$20.59B
Cash
$16.91B

For the twelve months ended Sep 27, 2026, from SEC filings. Not investment advice.

Latest news

25 items

Hiring

Nov 20, 2026

Johnson & Johnson lists 1,817 open roles on its careers site as of Nov 20, 2026, the most in MedTech Sales (403).

Open roles
1,817

By team

  • MedTech Sales
    403
  • Pharmaceutical Sales
    196
  • Finance
    98
  • Medical Affairs Group
    93
  • Supply Chain Engineering
    93
  • Career Programs
    75

By location

  • Chiyoda, Tokyo, Japan112
  • Raritan, New Jersey, United States of America98
  • Raynham, Massachusetts, United States of America78
  • Shanghai, China70
  • Titusville, New Jersey, United States of America58
  • Spring House, Pennsylvania, United States of America53

Counted daily from Johnson & Johnson's careers site.

JNJ rankings

News · 26 weeks94-24%
2026-05-31: 22026-06-07: 72026-06-14: 12026-06-21: 32026-06-28: 12026-07-05: 12026-07-12: 52026-07-19: 62026-07-26: 72026-08-02: 72026-08-09: 22026-08-16: 12026-08-23: 12026-08-30: 52026-09-06: 52026-09-13: 22026-09-20: 52026-09-27: 32026-10-04: 22026-10-11: 62026-10-18: 52026-10-25: 42026-11-01: 52026-11-08: 42026-11-15: 42026-11-22: 0
2026-05-312026-11-22
Mix5190d
  • Other36(71%)
  • Insider6(12%)
  • Earnings3(6%)
  • Analyst2(4%)
  • SEC Filings2(4%)
  • M&A2(4%)
Activity · 52 weeks227126 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Our reporting on JNJ

Johnson & Johnson (JNJ) is a Biotechnology: Pharmaceutical Preparations company listed on NYSE. In the last 30 days Quantisnow tracked 18 wire items for JNJ, including 15 press releases and news items, 2 M&A updates and 1 insider trade. The most recent was published Nov 20, 2026.

Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

JNJ FAQ

10 questions
  • What does Johnson & Johnson do?
    Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL...
  • What is JNJ revenue?
    Johnson & Johnson (JNJ) reported $99.33B of revenue for the twelve months ended Sep 27, 2026. That is up 7.8% from the year before. Revenue for fiscal 2025 was $94.19B.
  • Is JNJ profitable?
    Yes. Johnson & Johnson earned $16.09B in net income for the twelve months ended Sep 27, 2026, a net margin of 16.2%.
  • How much cash and debt does JNJ have?
    Johnson & Johnson reported $16.91B in cash and cash equivalents and $44.65B of debt on its most recent balance sheet in SEC filings.
  • Is Johnson & Johnson (JNJ) hiring?
    Johnson & Johnson lists 1,817 open roles on its careers site as of Nov 20, 2026, the most in MedTech Sales (403). The most openings are in Chiyoda, Tokyo, Japan, Raritan, New Jersey, United States of America and Raynham, Massachusetts, United States of America.
  • Where does JNJ stock trade?
    Johnson & Johnson (JNJ) is listed on NYSE.
  • What sector and industry is JNJ in?
    Johnson & Johnson operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • What are analysts saying about JNJ?
    Across the last 8 analyst actions on Johnson & Johnson, there were 4 upgrades and 1 downgrade. The most recent action was from Erste Group: Hold on 2026-10-21. Recent price targets range from $203.00 to $320.00.
  • What companies are similar to JNJ?
    Notable peers in the same industry include MRK (Merck & Company Inc.), ABT (Abbott Laboratories), PFE (Pfizer Inc.), MDT (Medtronic plc.), SYK (Stryker Corporation). Compare JNJ side-by-side with any of them on Quantisnow.
  • How can I track JNJ on Quantisnow?
    Quantisnow aggregates Johnson & Johnson's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow JNJ to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change